Eli Lilly and Innovent Biologics have expanded their collaboration deal and defined the distribution rights for up to three co-developed, experimental cancer drugs.
Stories Related to Eli Lilly And China’s Innovent Expand Partnership
WSJ.com About China, Wall Street Journal: World: China
Mon, 10/12/2015 - 3:52am
RELATED ARTICLES
- Stocks Fall as Investors Pause on Trade
Stocks fell, erasing early gains as investors continued to track trade negotiations between the U.S. and China as the two nations appear to inch closer to a pact. More - House Panel Requests Documents From Associates of Trump
Democrats intensified their investigations into President Trump and his associates, with House committees demanding records related to his business dealings, interactions with the Justice Department and communications with Russian President Vladimir Putin. More - U.S. Probes Titanium Imports in Possible Tariff Case
The Commerce Department will look into potential national-security risks in imports of the metal at the request of domestic producer Timet. More - China Accuses Detained Canadians of Espionage
China accused two detained Canadians of working together to steal Chinese state secrets, moving ahead with a politically charged investigation seen as retribution for Canada’s arrest of a senior Huawei executive. More - North Korea Still Using Uranium-Enrichment Facility, U.N. Agency Says
North Korea is still using a uranium-enrichment facility at the heart of last week’s summit between President Trump and North Korean leader Kim Jong Un, the United Nations atomic agency said. More - Purdue Pharma Preparing Possible Bankruptcy Filing
Purdue Pharma is working with advisers on a possible bankruptcy filing as it seeks to contain liability from suits alleging it fueled the U.S. opioid epidemic. More
BING NEWS:
- Eli Lilly and Company (LLY)
Market Chatter: Novo Nordisk, Eli Lilly's Weight-Loss Drugs Coverage Dropped by Blue Cross Blue Shield of Michigan If Eli Lilly's (LLY) donanemab is approved by the FDA, it will become the second ...
06/12/2024 - 5:00 am | View Link - Eli Lilly exec expects obesity pill data in April 2025
opens new tab late stage trial on experimental obesity pill orforglipron is expected in April 2025, a top Eli Lilly (LLY.N) , opens new tab executive said on Monday. The pill is part of a class of ...
06/10/2024 - 10:28 am | View Link - FDA panel makes the call on much-anticipated Alzheimer's drug donanemab
The recommendation came despite pointed questions from advisory committee members about the potential side effects of Eli Lilly's drug, an antibody that removes beta-amyloid that accumulates in ...
06/10/2024 - 10:11 am | View Link - FDA panel votes unanimously for Eli Lilly's Alzheimer's treatment
An FDA panel voted 11-0 Monday to recommend the use of Eli Lilly's (LLY) early-stage Alzheimer's treatment, known as donanemab. The monoclonal antibody drug, delivered through an IV monthly for up ...
06/10/2024 - 5:18 am | View Link - Eli Lilly’s Obesity Drug Crunch Shows Signs of Easing in Japan
Eli Lilly & Co.’s hefty investment in expanding production capacity for its popular weight-loss and diabetes drugs is starting to pay off in Japan, allowing the company to lift shipment controls ...
06/5/2024 - 1:00 pm | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more